IRAK-M Deficiency Promotes the Development of Type 1 Diabetes in NOD Mice
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IRAK-M Deficiency Promotes the Development of Type 1 Diabetes in NOD Mice
Authors
Keywords
-
Journal
DIABETES
Volume 63, Issue 8, Pages 2761-2775
Publisher
American Diabetes Association
Online
2014-04-03
DOI
10.2337/db13-1504
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IRAK-M mediates Toll-like receptor/IL-1R-induced NFκB activation and cytokine production
- (2013) Hao Zhou et al. EMBO JOURNAL
- Exacerbated Autoimmunity in the Absence of TLR9 in MRL.Faslpr Mice Depends on Ifnar1
- (2013) K. M. Nickerson et al. JOURNAL OF IMMUNOLOGY
- TLR9 Deficiency Promotes CD73 Expression in T Cells and Diabetes Protection in Nonobese Diabetic Mice
- (2013) N. Tai et al. JOURNAL OF IMMUNOLOGY
- Macrophage plasticity and polarization: in vivo veritas
- (2012) Antonio Sica et al. JOURNAL OF CLINICAL INVESTIGATION
- Interleukin-1 receptor-associated kinase-M suppresses systemic lupus erythematosus
- (2011) M. Lech et al. ANNALS OF THE RHEUMATIC DISEASES
- Accelerated progression from islet autoimmunity to diabetes is causing the escalating incidence of type 1 diabetes in young children
- (2011) Anette-G. Ziegler et al. JOURNAL OF AUTOIMMUNITY
- Inhibition of Autoimmune Diabetes by TLR2 Tolerance
- (2011) Do-Hoon Kim et al. JOURNAL OF IMMUNOLOGY
- Toll-Like Receptor 4 Is Involved in Inflammatory and Joint Destructive Pathways in Collagen-Induced Arthritis in DBA1J Mice
- (2011) Matthias Pierer et al. PLoS One
- The interleukin-1 receptor-associated kinases: Critical regulators of innate immune signalling
- (2010) Sinead Flannery et al. BIOCHEMICAL PHARMACOLOGY
- Toll-like Receptor 2 Signaling in CD4+ T Lymphocytes Promotes T Helper 17 Responses and Regulates the Pathogenesis of Autoimmune Disease
- (2010) Joseph M. Reynolds et al. IMMUNITY
- IL-1 receptor-associated kinase M downregulates DSS-induced colitis†
- (2010) Martin Berglund et al. INFLAMMATORY BOWEL DISEASES
- TLR9 Blockade Inhibits Activation of Diabetogenic CD8+ T Cells and Delays Autoimmune Diabetes
- (2010) Y. Zhang et al. JOURNAL OF IMMUNOLOGY
- A Role for IL-1 Receptor-Associated Kinase-M in Prostaglandin E2-Induced Immunosuppression Post-Bone Marrow Transplantation
- (2010) L. L. N. Hubbard et al. JOURNAL OF IMMUNOLOGY
- IRAK-M Removal Counteracts Dendritic Cell Vaccine Deficits in Migration and Longevity
- (2010) M. E. Turnis et al. JOURNAL OF IMMUNOLOGY
- Altered toll-like receptor signaling pathways in human type 1 diabetes
- (2010) Adam J. Meyers et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus
- (2010) Cristiana Guiducci et al. NATURE
- Chromogranin A is an autoantigen in type 1 diabetes
- (2010) Brian D Stadinski et al. NATURE IMMUNOLOGY
- Systemic Toll-Like Receptor Stimulation Suppresses Experimental Allergic Asthma and Autoimmune Diabetes in NOD Mice
- (2010) Aude Aumeunier et al. PLoS One
- Immunosuppression associated with interleukin-1R-associated-kinase-M upregulation predicts mortality in Gram-negative sepsis (melioidosis)
- (2009) Willem Joost Wiersinga et al. CRITICAL CARE MEDICINE
- TREM-1 Activation Alters the Dynamics of Pulmonary IRAK-M Expression In Vivo and Improves Host Defense during Pneumococcal Pneumonia
- (2009) H. Lagler et al. JOURNAL OF IMMUNOLOGY
- MyD88-induced downregulation of IRAK-4 and its structural requirements
- (2008) Fumihiko Hatao et al. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
- Innate immunity and intestinal microbiota in the development of Type 1 diabetes
- (2008) Li Wen et al. NATURE
- Toll-like receptors and autoimmunity
- (2007) Julia Hurst et al. AUTOIMMUNITY REVIEWS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started